Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).
Carmagnani Pestana R, Moyers JT, Roszik J, Sen S, Hong DS, Naing A, Herzog CE, Fu S, Piha-Paul SA, Rodon J, Yap TA, Karp DD, Tsimberidou AM, Pant S, Zarzour MA, Ratan R, Ravi V, Benjamin RS, Lazar AJ, Wang WL, Daw N, Gill JB, Harrison DJ, Lewis VO, Roland CL, Patel SR, Livingston JA, Somaiah N, Ludwig JA, Conley AP, Hamerschlak N, Gorlick R, Meric-Bernstam F, Subbiah V. Carmagnani Pestana R, et al. Among authors: hamerschlak n. Clin Cancer Res. 2023 May 1;29(9):1708-1718. doi: 10.1158/1078-0432.CCR-22-3629. Clin Cancer Res. 2023. PMID: 37058010 Free PMC article.
Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
Schvartsman G, Ma J, Bassett RL Jr, Haydu LE, Amaria RN, Hwu P, Wong MK, Hwu WJ, Diab A, Patel SP, Davies MA, Hamerschlak N, Tawbi HA, Glitza Oliva IC. Schvartsman G, et al. Among authors: hamerschlak n. Cancer. 2019 Dec 1;125(23):4193-4202. doi: 10.1002/cncr.32454. Epub 2019 Aug 9. Cancer. 2019. PMID: 31398264 Free article.
Impact of tissue-agnostic approvals for patients with sarcoma.
Pestana RC, Beal JR, Parkes A, Hamerschlak N, Subbiah V. Pestana RC, et al. Among authors: hamerschlak n. Trends Cancer. 2022 Feb;8(2):135-144. doi: 10.1016/j.trecan.2021.11.007. Epub 2021 Dec 6. Trends Cancer. 2022. PMID: 34887213 Review.
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).
Kantarjian H, Pasquini R, Lévy V, Jootar S, Holowiecki J, Hamerschlak N, Hughes T, Bleickardt E, Dejardin D, Cortes J, Shah NP. Kantarjian H, et al. Among authors: hamerschlak n. Cancer. 2009 Sep 15;115(18):4136-47. doi: 10.1002/cncr.24504. Cancer. 2009. PMID: 19536906 Free PMC article. Clinical Trial.
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma.
O'Connor OA, Özcan M, Jacobsen ED, Roncero JM, Trotman J, Demeter J, Masszi T, Pereira J, Ramchandren R, Beaven A, Caballero D, Horwitz SM, Lennard A, Turgut M, Hamerschlak N, d'Amore FA, Foss F, Kim WS, Leonard JP, Zinzani PL, Chiattone CS, Hsi ED, Trümper L, Liu H, Sheldon-Waniga E, Ullmann CD, Venkatakrishnan K, Leonard EJ, Shustov AR; Lumiere Study Investigators. O'Connor OA, et al. Among authors: hamerschlak n. J Clin Oncol. 2019 Mar 10;37(8):613-623. doi: 10.1200/JCO.18.00899. Epub 2019 Feb 1. J Clin Oncol. 2019. PMID: 30707661 Free PMC article. Clinical Trial.
Molecular profile of patients with myelofibrosis: a 10-year experience.
Dias LFS, Pereira CLM, Centurião NF, Nascimento JZMD, Ribeiro AAF, Hamerschlak N, Marques CP, Lima ACV, Costa LND, Silva AFD, Lima VJT, Kerbauy MN, Kerbauy LN, Arcuri LJ, Campregher PV, Rocha JDAD, Datoguia TS, Santos FPS. Dias LFS, et al. Among authors: hamerschlak n. Einstein (Sao Paulo). 2023 Jan 6;21:eAO0100. doi: 10.31744/einstein_journal/2023AO0100. eCollection 2023. Einstein (Sao Paulo). 2023. PMID: 36629680 Free PMC article.
Prognostic impact of RAS-pathway mutations in patients with myelofibrosis.
Santos FPS, Getta B, Masarova L, Famulare C, Schulman J, Datoguia TS, Puga RD, Alves Paiva RM, Arcila ME, Hamerschlak N, Kantarjian HM, Levine RL, Campregher PV, Rampal RK, Verstovsek S. Santos FPS, et al. Among authors: hamerschlak n. Leukemia. 2020 Mar;34(3):799-810. doi: 10.1038/s41375-019-0603-9. Epub 2019 Oct 18. Leukemia. 2020. PMID: 31628430 Free PMC article.
257 results